Trusted Resources
Mar 06, 2018
Bortezomib began to be used in the treatment of light chain (AL) amyloidosis in recent years. We performed the first meta-analysis of randomized clinical trials and…
Feb 11, 2018
Amyloidosis is a heterogeneous group of diseases characterised by extracellular accumulation of amyloid in various tissues and organs of the body, leading to…
Feb 01, 2018
Background:
The heart rate (HR) response to paced deep breathing (DB) is a common test of cardiac autonomic function, where high heart rate variability (HRV) is…
Jan 23, 2018
Background:
To investigate obesity as susceptibility factor in patients with idiopathic AA amyloidosis.
Methods:
Clinical, biochemical and genetic data were…
Jan 21, 2018
Background:
Chronic physical illness has been associated with emotional distress. Chronic diseases may change usual family patterns with economic, social and family…
Jan 09, 2018
The most common form of systemic amyloidosis in Western countries is light chain amyloidosis. It is characterized by the deposition of a misfolded light chain in…
Jan 04, 2018
Rationale:
Dialysis-related amyloidosis (DRA) can present rheumatic manifestations in patients on long-term hemodialysis. Typical articular symptoms with DRA…